Conquering Diseases

Study Of An Investigational Drug For Endometrial Cancer

Description

Seeking women whose endometrial cancer has previously been treated with platinum-based chemotherapy and immunotherapy for a study of an investigational drug.

Overview

Participants in this study will be randomly assigned to get either the investigational drug or the usual treatment. The drugs are given as an IV infusion every 2 weeks for the investigational drug or every 3-4 weeks for the usual treatment.

What we're hoping for

We are studying whether an investigational drug is better, worse, or the same as the usual treatment for endometrial cancer previously treated with platinum-based chemotherapy and immunotherapy.

Additional Information

ClinicalTrials.gov Identifier: NCT06132958

 Principal Investigator

Susan  Zweizig, MD

UMass Memorial Health

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMH Memorial Campus

281 Lincoln St. 

Worcester,MA 01605

508-334-1000